Reasons for excluding adverse events in cost-effectiveness analyses of vaccines: A survey amongst authors

Although vaccines must adhere to the strictest safety standards in medicine, adverse events (AE) do occur occasionally. Even when clinically negligeable, these AE can still have health-economic implications, affecting the cost-effectiveness of vaccines. A review revealed that only 25 % of recent hea...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Vaccine Jg. 61; S. 127341
Hauptverfasser:	Luyten, Jeroen, van Hoek, Albert Jan
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Netherlands Elsevier Ltd 13.08.2025 Elsevier Limited
Schlagworte:	Adverse events Allergy and Immunology childhood Children Cost analysis Cost effectiveness Cost-Benefit Analysis Data collection Decision making Drug-Related Side Effects and Adverse Reactions - economics Economic evaluation Economics Guillain-Barre syndrome HTA Human papillomavirus Humans Immunization medicine Response rates Rotavirus Side effects surveys Surveys and Questionnaires Vaccination Vaccination - adverse effects Vaccination - economics Vaccines Vaccines - adverse effects Vaccines - economics Viruses Europe Side effects HTA Cost-effectiveness Vaccination Economic evaluation
ISSN:	0264-410X, 1873-2518, 1873-2518
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!